SMTL ID : 5k4j.1

Crystal Structure of CDK2 in complex with compound 22

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.60 Å

Oligo State

monomer

Ligands

1 x 6QB: 1-[(1~{S})-1-(4-chloranyl-3-fluoranyl-phenyl)-2-oxidanyl-ethyl]-4-[2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]pyridin-2-one(Non-covalent)

6QB.1: 20 residues within 4Å: Chain A: I.11, G.12, E.13, G.14, Y.16, G.17, V.18, V.19, A.32, K.34, E.82, F.83, L.84, H.85, D.87, K.90, Q.132, N.133, L.135, D.146 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:V.19, A:A.32, A:L.135, A:L.135 Hydrogen bonds: A:L.84, A:L.84, A:K.90 Water bridges: A:D.146 Halogen bonds: A:G.17

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Blake, J.F. et al., Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development. J.Med.Chem. (2016)

Release Date

2016-07-06

Peptides

Cyclin-dependent kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cyclin-dependent kinase 2